Episodios

  • Our Excellence Spotlight series celebrates and showcases the remarkable journeys and achievements of RQM+ employees; the same employees who are committed to technical excellence and make a significant impact on our clients.

    An 18-yr old McDonald's manager at Purdue University's campus restaurant just so happened to find her ๐—พ๐˜‚๐—ฎ๐—น๐—ถ๐˜๐˜† ๐—บ๐—ถ๐—ป๐—ฑ๐˜€๐—ฒ๐˜ ๐Ÿ“‹โœ“ making consistently perfect burgers.

    Today, Carrie (Habegger) Schneider is a Principal Consultant at RQM+, with three (!) degrees ๐Ÿ“š earned while raising three (!) kids ๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ

    Her expertise in ๐—ฝ๐—ผ๐˜€๐˜-๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐˜€๐˜‚๐—ฟ๐˜ƒ๐—ฒ๐—ถ๐—น๐—น๐—ฎ๐—ป๐—ฐ๐—ฒ and ๐—ฐ๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฒ๐˜ƒ๐—ฎ๐—น๐˜‚๐—ฎ๐˜๐—ถ๐—ผ๐—ป keeps medical devices safe for patients worldwide.

    ๐ŸฅWatch her relatable and remarkable journey in our latest ๐—˜๐˜…๐—ฐ๐—ฒ๐—น๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฆ๐—ฝ๐—ผ๐˜๐—น๐—ถ๐—ด๐—ต๐˜!

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • *This video is part of our educational video series on clinical trials. Clips will cover three key areas: clinical trial strategy, clinical trial execution, and regulatory expertise in clinical trials. Please โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ reach out to RQM+โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ  if you need support with clinical trials.*

    ๐ŸŽฏ ๐—ช๐—ต๐—ฎ๐˜ ๐—บ๐—ฎ๐—ธ๐—ฒ๐˜€ ๐—ฎ ๐˜€๐˜‚๐—ฐ๐—ฐ๐—ฒ๐˜€๐˜€๐—ณ๐˜‚๐—น ๐—ฟ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜€๐˜€๐—ถ๐—ผ๐—ป ๐—ณ๐—ฟ๐—ผ๐—บ ๐—ฎ ๐—ฐ๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐˜๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฝ๐—ฒ๐—ฟ๐˜€๐—ฝ๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐—œ๐—ฉ๐——๐˜€?

    Did you know 60-80% of IVD 510(k)s require clinical data?

    In this must-watch video, Director of IVD Global Regulatory Affairs Margot Borgel, Ph.D. is joined by Nancy Morrison, RAC (with 30+ years of regulatory experience) and they break down the make-or-break factors in IVD submissions.

    ๐—ž๐—ฒ๐˜† ๐˜๐—ฎ๐—ธ๐—ฒ๐—ฎ๐˜„๐—ฎ๐˜†๐˜€:

    โ€“ Why clinical data is non-negotiable for modern IVD submissions

    โ€“ Critical FDA & EU regulatory expectations for clinical evidence

    โ€“ How to avoid costly study design mistakes

    โ€“ Smart strategies for patient population selection

    โ€“ Key considerations for diversity in clinical trials

    โ€“ Tips for navigating the IVDR transition period

    ๐—•๐—ผ๐—ป๐˜‚๐˜€ ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜: Learn why "baby steps" in regulatory strategy might actually ๐˜จ๐˜ฆ๐˜ต ๐˜บ๐˜ฐ๐˜ถ ๐˜ต๐˜ฐ ๐˜ฎ๐˜ข๐˜ณ๐˜ฌ๐˜ฆ๐˜ต ๐˜ง๐˜ข๐˜ด๐˜ต๐˜ฆ๐˜ณ!

    Don't miss this expert guidance on avoiding the pitfalls that could force you to restart your entire clinical program.

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • ¿Faltan episodios?

    Pulsa aquí para actualizar resultados

  • Our Excellence Spotlight series celebrates and showcases the remarkable journeys and achievements of RQM+ employees; the same employees who are committed to technical excellence and make a significant impact on our clients.

    ๐Ÿง—โ€โ™€๏ธ Our newest ๐—˜๐˜…๐—ฐ๐—ฒ๐—น๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฆ๐—ฝ๐—ผ๐˜๐—น๐—ถ๐—ด๐—ต๐˜ interview is an especially fun one! From National Geographic subscriptions to successfully navigating FDA submissions, meet Senior Consultant Holly Cotter, RAC, CBA.

    Driven by a palpable curiosity since childhood, she's transformed her love for learning into a thriving hashtag#MedTech career and currently brings ๐™ž๐™ข๐™ข๐™š๐™ฃ๐™จ๐™š value to RQM+ clients.

    In this spotlight, Holly shares:

    ๐Ÿงฌ Her path from bioengineering to hands-on clinical experience with artificial hearts ๐Ÿ”ฌ The valuable lessons learned from working in a 10-person startup ๐Ÿ“ˆ How she turned an FDA "not substantially equivalent" letter into a 32-day clearance win โœ๏ธ Her recent venture into authorship for regulatory publications (hint โ†’ Regulatory Affairs Professionals Society (RAPS))

    There MIGHT have been a Grey's Anatomy reference, too. Maybe. ๐Ÿ˜‰

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • *This video is part of our educational video series on clinical trials. Clips will cover three key areas: clinical trial strategy, clinical trial execution, and regulatory expertise in clinical trials. Please โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ reach out to RQM+โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ  if you need support with clinical trials.*

    In the final installment of this three-part series, Jaishankar Kutty, Ph.D. concludes the discussion with former FDA lead reviewer Ryan Randall and ex-BSI clinical compliance head Amie Smirthwaite (current RQM+ Senior VP of Scientific Affairs) on the intricacies of successful regulatory submissions in clinical trials.

    Key topics covered:

    Critical study design elements that can make or break a regulatory submission Navigating global clinical studies and patient population requirements The importance of ISO 14155 compliance in EU submissions Special considerations for niche and orphan devices US Humanitarian Device Exemption (HDE) pathway insights Future developments in EU pathways for rare disease technologies Strategies for managing studies with limited patient populations

    These experts provide crucial insights into avoiding common pitfalls in study design and execution, while offering unique perspectives on specialized regulatory pathways for rare diseases and underserved populations.

    Learn how to navigate these complex regulatory landscapes and optimize your submission strategy for success in both US and EU markets.

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • This presentation and panel was recorded 4 October 2024. We encourage you to download the slides presented during this session by โ โ โ โ โ โ โ completing the form on this pageโ โ โ โ โ โ โ . Please join us live for future shows for the chance to participate in the chat and ask your own questions!

    We generally hold one RQM+ Live! panel discussion per month (in addition to occasional traditional webinars) and you can sign up for these events and more at the โ โ โ โ โ โ โ โ Knowledge Centerโ โ โ โ โ โ โ โ  โ โ โ โ โ โ at RQMplus.com.

    Thank you for tuning in. ๐Ÿ™

    Join us for an exclusive panel discussion featuring top experts from TรœV SรœD, GMED, and BSI as they dive into the intricacies of structured dialogue between MedTech manufacturers and notified bodies. As regulatory expectations continue to evolve under MDR and IVDR, these dialogues are vital for ensuring compliance and expediting market access.

    Our panelists will provide valuable insights into key topics such as:

    Effective strategies for engaging with notified bodies in structured dialogues Managing device classifications, submission processes, and project timelines How to navigate changes in notified bodies and maintain compliance Best practices for developing regulatory plans in new technology areas

    This session is ideal for regulatory professionals, quality assurance teams, and MedTech manufacturers seeking practical guidance on optimizing their interactions with notified bodies.

    Don't miss this opportunity to learn from leading voices in the industry and gain actionable strategies to ensure regulatory success. This session will be invaluable for anyone navigating MDR/IVDR compliance.

    Panelists:

    Alex Laan โ€“ Head of the IVD Notified Body, BSI Dr. Andreas Stange โ€“ Senior Vice President MHS Regulatory & Quality, TรœV SรœD Tom Patten โ€“ IVDR/IVD International Manager, GMED

    Moderator:

    Jaishankar (Jai) Kutty, Ph.D. โ€“ Vice President, Global Regulatory Affairs, RQM+

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • *This video is part of our educational video series on clinical trials. Clips will cover three key areas: clinical trial strategy, clinical trial execution, and regulatory expertise in clinical trials. Please โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ reach out to RQM+โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ  if you need support with clinical trials.*

    In part two of a three-part series, Jaishankar Kutty, Ph.D. continues the discussion with former FDA lead reviewer Ryan Randall and ex-BSI clinical compliance head Amie Smirthwaite (current RQM+ Senior VP of Scientific Affairs) on the intricacies of successful regulatory submissions in clinical trials.

    Key topics covered:

    Challenges in demonstrating safety and performance/efficacy for medical devices Differences between FDA and EU approaches to clinical evidence The impact of evolving device designs on clinical studies Importance of pre-submission meetings with regulatory bodies Complexities of the EU reimbursement landscape Strategies for dealing with small sample sizes in clinical data The shift in the EU regulatory landscape and its impact on manufacturers

    Whether you're a seasoned professional or new to the field, this discussion offers crucial perspectives on optimizing your regulatory submission strategy for medical devices and IVDs in both the US and EU markets.

    Don't miss this opportunity to learn from top industry experts and enhance your understanding of the regulatory review process in clinical trials!

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • Our Excellence Spotlight series celebrates and showcases the remarkable journeys and achievements of RQM+ employees; the same employees who are committed to technical excellence and make a significant impact on our clients.

    โญ After highlighting many members of our Jordi Labs, an RQM+ Company team in the past two months, we're returning to RA/QA this week.

    Today we're delighted to share Jaishankar Kutty, Ph.D.'s ๐—˜๐˜…๐—ฐ๐—ฒ๐—น๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฆ๐—ฝ๐—ผ๐˜๐—น๐—ถ๐—ด๐—ต๐˜ interview with Principal Consultant, Christine Anderson, RAC.

    Learn how Christine's journey from microbiology to becoming an ๐—ฎ๐—น๐—น-๐—ฟ๐—ผ๐˜‚๐—ป๐—ฑ ๐—ฟ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐˜€๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ฎ๐—น๐—ถ๐˜€๐˜ has shaped her into a genuine leader in the field.

    Christine shares:

    โœ”๏ธ Her transition from R&D to regulatory affairs

    โœ”๏ธ The importance of thorough background research and curiosity in regulatory work

    โœ”๏ธ Her approach to building long-term client relationships

    โœ”๏ธ The rewards of helping clients

    โœ”๏ธ How diverse client interactions continually broaden her expertise

    We hope you enjoy this conversation and stay tuned as we highlight more of our RA/QA experts in the coming weeks! ๐ŸŒŸ

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • *This video is part of our educational video series on clinical trials. Clips will cover three key areas: clinical trial strategy, clinical trial execution, and regulatory expertise in clinical trials. Please โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ reach out to RQM+โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ  if you need support with clinical trials.*

    In part one of a three part series, Jaishankar Kutty, Ph.D. hosts former FDA lead reviewer Ryan Randall and ex-BSI clinical compliance head Amie Smirthwaite (current RQM+ Senior VP of Scientific Affairs) to unpack the intricacies of successful regulatory submissions in clinical trials.

    Key topics covered:

    Essential stakeholders in the clinical trial approval process for both US and EU markets The importance of early engagement with regulatory bodies and payers Reviewer approaches to clinical data sets and benefit-risk analyses Strategies for navigating failed primary endpoints The balance between statistical and clinical significance in regulatory decision-making Differences in approach between MDD and MDR in the EU The impact of study design and protocol adherence on regulatory review

    These experts provide invaluable insights into the mindset of regulatory reviewers, offering guidance on how to present clinical data effectively and navigate complex regulatory landscapes.

    Whether you're a seasoned professional or new to the field, this discussion offers crucial perspectives on optimizing your regulatory submission strategy for medical devices and IVDs in both the US and EU markets.

    Don't miss this opportunity to learn from top industry experts and enhance your understanding of the regulatory review process in clinical trials!

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • Our Excellence Spotlight series celebrates and showcases the remarkable journeys and achievements of RQM+ employees; the same employees who are committed to technical excellence and make a significant impact on our clients.

    ๐Ÿงช Our run of ๐—˜๐˜…๐—ฐ๐—ฒ๐—น๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฆ๐—ฝ๐—ผ๐˜๐—น๐—ถ๐—ด๐—ต๐˜ interviews with our Jordi Labs, an RQM+ Company team members continues with Christine Santagate, RAC chatting with Senior Chemist II and supervisor of our gas and liquid chromatography teams, Michael Louis, Ph. D.

    Listen in to hear how Mike became a ๐—ฟ๐—ฒ๐˜€๐—ฝ๐—ฒ๐—ฐ๐˜๐—ฒ๐—ฑ ๐—น๐—ฒ๐—ฎ๐—ฑ๐—ฒ๐—ฟ ๐—ฎ๐—ป๐—ฑ ๐—บ๐—ฒ๐—ป๐˜๐—ผ๐—ฟ, known for his extensive chemistry expertise and collaborative approach. ๐Ÿ‘จโ€๐Ÿ”ฌ

    In the interview Mike shares:

    โœ”๏ธ His journey from University of Massachusetts Amherst to University of New Hampshire, and finally, to Jordi Labs, an RQM+ Company

    โœ”๏ธ The excitement of working with cutting-edge instrumentation to solve complex problems

    โœ”๏ธ His experience developing methods for detecting fluorinated compounds at ultra-low levels

    โœ”๏ธ How management support enables innovative problem-solving

    โœ”๏ธ Valuable advice for newcomers to the industry

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • *This video is part of our educational video series on clinical trials. Clips will cover three key areas: clinical trial strategy, clinical trial execution, and regulatory expertise in clinical trials. Please โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ reach out to RQM+โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ  if you need support with clinical trials.*

    ๐Ÿšจ Watch our newest video to learn best practices for ๐—ฎ๐—ฑ๐˜ƒ๐—ฒ๐—ฟ๐˜€๐—ฒ ๐—ฒ๐˜ƒ๐—ฒ๐—ป๐˜ ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜๐—ถ๐—ป๐—ด ๐—ถ๐—ป ๐—ฐ๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐˜๐—ฟ๐—ถ๐—ฎ๐—น๐˜€.

    Manager of Safety Management Melanie Miller reveals:

    ๐Ÿ“Š AE definitions for medical devices vs. drugs

    ๐ŸŒ Global reporting requirements and timelines

    ๐Ÿ“‹ Minimum data set for reportable AEs

    ๐Ÿ”ฌ Reporting differences across study types

    Elevate your clinical trial expertise with RQM+ (this is the 21st video in our clinical trials-specific video series this year) and ensure regulatory compliance.

    Reminder that you can find all of our clinical trial videos in other places, too. ๐Ÿ‘‡

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ LinkedInโ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“บ โ โ โ โ โ โ โ โ โ โ โ The RQM+ YouTube channelโ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ง For support with clinical trials, please โ โ โ โ โ โ โ โ โ โ โ contact us directlyโ โ โ โ โ โ โ โ โ โ โ .

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • *This video is part of our educational video series on clinical trials. Clips will cover three key areas: clinical trial strategy, clinical trial execution, and regulatory expertise in clinical trials. Please โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ reach out to RQM+โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ  if you need support with clinical trials.*

    In our latest clinical trials video, Manager of Safety Management Melanie Miller joins Jaishankar Kutty, Ph.D. to discuss the ๐—ฐ๐—ฟ๐—ถ๐˜๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฎ๐˜€๐—ฝ๐—ฒ๐—ฐ๐˜๐˜€ ๐—ผ๐—ณ ๐—ฒ๐—ณ๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—ฒ๐—ณ๐—ณ๐—ถ๐—ฐ๐—ถ๐—ฒ๐—ป๐˜ ๐˜€๐—ฎ๐—ณ๐—ฒ๐˜๐˜† ๐—บ๐—ฎ๐—ป๐—ฎ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐—ถ๐—ป ๐—ฐ๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐˜๐—ฟ๐—ถ๐—ฎ๐—น๐˜€.

    Melanie covers:

    ๐Ÿ“‹ Key components of effective safety management

    ๐Ÿ”ฌ Pre-enrollment planning and study protocol design

    ๐Ÿ“Š Importance of comprehensive safety management plan

    ๐Ÿ’ป Leveraging digital-first mindsets and automation

    ๐Ÿค Breaking down silos for improved communication

    ๐ŸŽ“ Ongoing training and education for all stakeholders

    ๐Ÿ”„ Continuous improvement in safety processes

    ๐—ฌ๐—ผ๐˜‚'๐—น๐—น ๐—น๐—ฒ๐—ฎ๐—ฟ๐—ป ๐—ฎ๐—ฏ๐—ผ๐˜‚๐˜ ๐˜๐—ต๐—ฒ ๐—น๐—ฎ๐˜๐—ฒ๐˜€๐˜ ๐˜๐—ฟ๐—ฒ๐—ป๐—ฑ๐˜€ ๐—ถ๐—ป ๐˜€๐—ฎ๐—ณ๐—ฒ๐˜๐˜† ๐—บ๐—ฎ๐—ป๐—ฎ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜, ๐˜๐—ผ๐—ผ, ๐—ถ๐—ป๐—ฐ๐—น๐˜‚๐—ฑ๐—ถ๐—ป๐—ด:

    ๐Ÿค– AI and machine learning in safety data analysis

    ๐Ÿ“ฑ Digital health technologies for real-time patient reporting

    ๐Ÿ‘ฅ The roles of key players in the safety management process

    There's a lot here! Effective safety management is crucial for maintaining data integrity, ensuring regulatory compliance, and most importantly, safeguarding patient well-being throughout the clinical trial process.

    Reminder that you can find all of our clinical trial videos in other places, too. ๐Ÿ‘‡

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ LinkedInโ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“บ โ โ โ โ โ โ โ โ โ โ The RQM+ YouTube channelโ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ง For support with clinical trials, please โ โ โ โ โ โ โ โ โ โ contact us directlyโ โ โ โ โ โ โ โ โ โ .

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • This presentation and panel was recorded 12 September 2024. We encourage you to download the slides presented during this session by โ โ โ โ โ โ completing the form on this pageโ โ โ โ โ โ . Please join us live for future shows for the chance to participate in the chat and ask your own questions!

    We generally hold one RQM+ Live! panel discussion per month (in addition to occasional traditional webinars) and you can sign up for these events and more at the โ โ โ โ โ โ โ Knowledge Centerโ โ โ โ โ โ โ  โ โ โ โ at RQMplus.com.

    Thank you for tuning in. ๐Ÿ™

    The recently published Regulation (EU) 2024/1860 amends the EU Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) by introducing some significant changes that will impact manufacturers and the entire MedTech industry.

    One of the changes is the introduction of a requirement for manufacturers to inform national competent authorities in cases of supply chain interruptions, or the withdrawal from the market, of certain critical medical devices and IVDs.

    Join our expert panel to explore the implications of these new obligations for manufacturers and learn actionable strategies to ensure compliance.

    In this comprehensive discussion, our regulatory and quality experts will cover:

    Impact Assessment: An overview of the amendments, including changes to transition timelines for IVDR and the phased rollout of EUDAMED. Supply Chain Management: Insights into the new obligation for manufacturers to provide advanced notice of supply chain interruptions and strategies to ensure a robust and resilient supply chain. Industry Perspectives: An examination of feedback from industry stakeholders and how companies are preparing for these regulatory changes. Compliance Strategies: Guidance on meeting the new requirements, including implementation within your Quality Management System (QMS). Quality and Regulatory Support: How RQM+ can support your company with regulatory change assessments, EUDAMED data management, and the implementation of new supply chain notification processes.

    By attending this event, you will gain a clear understanding of the amendments to MDR and IVDR and learn practical steps and strategies to achieve compliance. Register now to stay ahead of these critical regulatory changes and ensure the continued success of your products in the European market.

    Panelists and moderator:

    Erik Vollebregt โ€“ Advocaat, Axon Science Based Lawyers Heike Moehlig-Zuttermeister โ€“ Global Director In-Vitro Diagnostics, TรœV SรœD Donielle Johnson โ€“ Global Regulatory Affairs Executive Ed Ball โ€“ Manager, Intelligence & Strategic Execution, RQM+ Amie Smirthwaite, Ph.D. โ€“ Senior Vice President, Scientific Affairs, RQM+ (moderator)

    Certificate of Participation available upon request for live attendees.

    Who Should Attend: This panel discussion is ideal for regulatory affairs professionals, operations management, quality assurance professionals, production planning and supply chain managers, and MedTech manufacturers navigating the amended IVDR and MDR requirements.

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • Our Excellence Spotlight series celebrates and showcases the remarkable journeys and achievements of RQM+ employees; the same employees who are committed to technical excellence and make a significant impact on our clients.

    ๐Ÿงช Our ๐—˜๐˜…๐—ฐ๐—ฒ๐—น๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฆ๐—ฝ๐—ผ๐˜๐—น๐—ถ๐—ด๐—ต๐˜ interview series continues as Christine Santagate, RAC chats with Dr. Anthony Grice, a leading chemist at Jordi Labs for over a decade!

    Discover how "Ant" became our go-to ๐—–๐—ฆ๐—œ ๐—ผ๐—ณ ๐—–๐—ต๐—ฒ๐—บ๐—ถ๐˜€๐˜๐—ฟ๐˜† ๐Ÿ•ต๏ธโ€โ™‚๏ธ, solving complex problems with creativity. Ant shares:

    โœ”๏ธ His journey from the UK to becoming a polymer chemistry expert

    โœ”๏ธ The excitement of tackling diverse challenges in analytical chemistry

    โœ”๏ธ His experience with GPC and its applications in #medicaldevices

    ๐Ÿ”จ Some unconventional methods used to solve client problems (sledgehammer, anyone?)

    โœ”๏ธ Valuable advice for aspiring chemists and regulatory professionals

    From deformulating golf balls to smashing solar panels, we hope Ant's interview inspires you and showcases the problem-solving ingenuity of RQM+/Jordi Labs staff.

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • Our Excellence Spotlight series celebrates and showcases the remarkable journeys and achievements of RQM+ employees; the same employees who are committed to technical excellence and make a significant impact on our clients.

    ๐Ÿงช Our ๐—˜๐˜…๐—ฐ๐—ฒ๐—น๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฆ๐—ฝ๐—ผ๐˜๐—น๐—ถ๐—ด๐—ต๐˜ interview series continues this week, as Christine Santagate, RAC is joined by Lab Coordinator Craig Young of the Jordi Labs team.

    ๐Ÿ‘จโ€๐Ÿ”ฌ Discover how Craig's diverse background in chemistry and project management led him to become an ๐—ฒ๐˜€๐˜€๐—ฒ๐—ป๐˜๐—ถ๐—ฎ๐—น ๐—ฝ๐—ฎ๐—ฟ๐˜ ๐—ผ๐—ณ ๐—ผ๐˜‚๐—ฟ ๐—ผ๐—ฝ๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€.

    Craig shares:

    โœ”๏ธ His journey from WPI to Las Vegas and back to Mansfield

    โœ”๏ธ Experiences in biodiesel production and laboratory startups

    โœ”๏ธ How his "jack-of-all-trades" nature suits lab coordination

    โœ”๏ธ His role in implementing ClickUp for project management

    โœ”๏ธ Valuable advice for those entering the scientific industry

    โš—๏ธ We'll be continuing to highlight more Jordi Labs all-star team members in the coming weeks, so stay tuned.

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • Our Excellence Spotlight series celebrates and showcases the remarkable journeys and achievements of RQM+ employees; the same employees who are committed to technical excellence and make a significant impact on our clients.

    ๐Ÿงช Our ๐—˜๐˜…๐—ฐ๐—ฒ๐—น๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฆ๐—ฝ๐—ผ๐˜๐—น๐—ถ๐—ด๐—ต๐˜ interview series continues this week, as Christine Santagate, RAC is joined by Chemist II Michael Morales of the Jordi Labs team.

    ๐Ÿ‘จโ€๐Ÿ”ฌ Discover how Michael's passion for chemistry led him to becoming a ๐˜๐—ฟ๐˜‚๐—ฒ ๐—ฒ๐˜…๐—ฝ๐—ฒ๐—ฟ๐˜ ๐—ถ๐—ป ๐—ด๐—ฎ๐˜€ ๐—ฐ๐—ต๐—ฟ๐—ผ๐—บ๐—ฎ๐˜๐—ผ๐—ด๐—ฟ๐—ฎ๐—ฝ๐—ต๐˜†.

    Michael shares:

    โœ”๏ธ His journey through academia and into industry

    โœ”๏ธ The importance of perseverance in scientific research

    โœ”๏ธ His experience in tackling complex projects and method development

    โœ”๏ธ The rewards of mentoring and giving back to the scientific community

    โœ”๏ธ Valuable advice for those considering a career in chemistry

    ๐Ÿ”ฌ Check out the interview to learn from Michael's expertise and hopefully be inspired by his enthusiasm for analytical chemistry as well!

    We plan to continue to highlight many more all-star employees from Jordi Labs in the coming weeks, so stay tuned.

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • *This video is part of our educational video series on clinical trials. Clips will cover three key areas: clinical trial strategy, clinical trial execution, and regulatory expertise in clinical trials. Please โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ reach out to RQM+โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ  if you need support with clinical trials.*

    In our third and final clinical trials video focused on data management, Senior Director of Data Operations Noel Keegan returns to speak with Jaishankar Kutty, Ph.D. about the ๐—ฐ๐—ฟ๐—ถ๐˜๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฟ๐—ผ๐—น๐—ฒ ๐—ผ๐—ณ ๐—–๐—ฅ๐—ข๐˜€ ๐—ถ๐—ป ๐—ฑ๐—ฎ๐˜๐—ฎ ๐—บ๐—ฎ๐—ป๐—ฎ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜.

    Noel covers:

    ๐Ÿค The importance of partnership between CROs and sponsors

    ๐Ÿ† Key performance and quality indicators across all trial phases

    ๐Ÿ” Independent quality review processes

    ๐Ÿ“š Leveraging standardized libraries and best practices

    ๐ŸŽฏ Tailoring services to meet specific sponsor needs

    In the end, a CRO should act as an extension of the sponsor's team, providing expertise, accountability, and flexibility throughout the clinical trial process.

    Reminder that you can find all of our clinical trial videos in other places, too. ๐Ÿ‘‡

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ LinkedInโ โ โ โ โ โ โ โ โ 

    ๐Ÿ“บ โ โ โ โ โ โ โ โ โ The RQM+ YouTube channelโ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ง For support with clinical trials, please โ โ โ โ โ โ โ โ โ contact us directlyโ โ โ โ โ โ โ โ โ .

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • Our Excellence Spotlight series celebrates and showcases the remarkable journeys and achievements of RQM+ employees; the same employees who are committed to technical excellence and make a significant impact on our clients.

    ๐Ÿ‘จโ€๐Ÿ”ฌ Our ๐—˜๐˜…๐—ฐ๐—ฒ๐—น๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฆ๐—ฝ๐—ผ๐˜๐—น๐—ถ๐—ด๐—ต๐˜ short interview series continues this week, as Christine Santagate, RAC is joined by another member of the Jordi Labs team, Tommy Kumlin.

    See how Tommy's background in chemistry and chemical engineering led him to become a jack-of-all-trades in analytical techniques. ๐Ÿ”ฌ

    Tommy shares:

    โœ”๏ธ His specialization in spectroscopy, microscopy, and thermal analysis

    โœ”๏ธ How he combines different techniques for comprehensive analysis

    โœ”๏ธ The satisfaction of instrument troubleshooting and maintenance

    โœ”๏ธ The importance of collaboration in a professional environment

    โœ”๏ธ Valuable advice for those entering the industry

    Stay tuned as we plan to highlight additional Jordi Labs staff in the coming weeks! ๐Ÿงซ

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • *This video is part of our educational video series on clinical trials. Clips will cover three key areas: clinical trial strategy, clinical trial execution, and regulatory expertise in clinical trials. Please โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ reach out to RQM+โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ  if you need support with clinical trials.*

    ๐ŸŽ‰ The data management party continues!

    Part 2 of our clinical trial data management series is here! Jaishankar Kutty, Ph.D. welcomes back Senior Director of Data Operations, Noel Keegan, to dive into the ๐—บ๐—ฎ๐—ถ๐—ป๐˜๐—ฒ๐—ป๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—ฐ๐—น๐—ผ๐˜€๐—ฒ๐—ผ๐˜‚๐˜ ๐—ฝ๐—ต๐—ฎ๐˜€๐—ฒ๐˜€ of clinical trial data management.

    In this discussion, Noel covers:

    ๐Ÿ“Š Data validation activities post-database build

    ๐Ÿ”„ Managing external data from core labs, imaging, and safety

    ๐Ÿ“ˆ Sharing validation progress with sponsors

    ๐Ÿ”’ Database lock timelines and best practices

    ๐Ÿ“ฆ Archiving processes and considerations

    ๐Ÿ’ก Key takeaway: Proactive data cleaning during the maintenance phase leads to a smoother, faster database lock!

    ๐ŸŽฌ Missed Part 1? Check out our previous video on the study setup phase of data management.

    Reminder that you can find all of our clinical trial videos in other places, too. ๐Ÿ‘‡

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ LinkedInโ โ โ โ โ โ โ โ 

    ๐Ÿ“บ โ โ โ โ โ โ โ โ The RQM+ YouTube channelโ โ โ โ โ โ โ โ 

    ๐Ÿ“ง For support with clinical trials, please โ โ โ โ โ โ โ โ contact us directlyโ โ โ โ โ โ โ โ .

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • *This video is part of our educational video series on clinical trials. Clips will cover three key areas: clinical trial strategy, clinical trial execution, and regulatory expertise in clinical trials. Please โ โ โ โ โ โ โ โ โ โ โ โ โ โ reach out to RQM+โ โ โ โ โ โ โ โ โ โ โ โ โ โ  if you need support with clinical trials.*

    ๐ŸŽ‰ It's a data management party โ€“ you in?

    Our team had a ton of fun recording the newest video in our clinical trial video series and it's now available. Jaishankar Kutty, Ph.D. speaks with Senior Director of Data Operations, Noel Keegan, about ๐—ฒ๐—ณ๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ฑ๐—ฎ๐˜๐—ฎ ๐—บ๐—ฎ๐—ป๐—ฎ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐—ถ๐—ป ๐—ฐ๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐˜๐—ฟ๐—ถ๐—ฎ๐—น๐˜€, specifically focusing on the study setup phase.

    More particularly, Noel covers selecting appropriate electronic data capture systems, database setup timelines and risks, and considerations for data integration across platforms.

    ๐Ÿ’พ ๐˜›๐˜ฉ๐˜ฆ ๐˜ฏ๐˜ฆ๐˜น๐˜ต ๐˜ต๐˜ธ๐˜ฐ ๐˜ท๐˜ช๐˜ฅ๐˜ฆ๐˜ฐ๐˜ด ๐˜ธ๐˜ช๐˜ญ๐˜ญ ๐˜ข๐˜ญ๐˜ด๐˜ฐ ๐˜ฑ๐˜ฆ๐˜ณ๐˜ต๐˜ข๐˜ช๐˜ฏ ๐˜ต๐˜ฐ ๐˜ฅ๐˜ข๐˜ต๐˜ข ๐˜ฎ๐˜ข๐˜ฏ๐˜ข๐˜จ๐˜ฆ๐˜ฎ๐˜ฆ๐˜ฏ๐˜ต, ๐˜ด๐˜ฐ ๐˜ฌ๐˜ฆ๐˜ฆ๐˜ฑ ๐˜ข๐˜ฏ ๐˜ฆ๐˜บ๐˜ฆ ๐˜ฐ๐˜ถ๐˜ต.

    Reminder that you can find all of our clinical trial videos in other places, too. ๐Ÿ‘‡

    ๐Ÿ’ผ โ โ โ โ โ โ โ LinkedInโ โ โ โ โ โ โ 

    ๐Ÿ“บ โ โ โ โ โ โ โ The RQM+ YouTube channelโ โ โ โ โ โ โ 

    ๐Ÿ“ง For support with clinical trials, please โ โ โ โ โ โ โ contact us directlyโ โ โ โ โ โ โ .

    --

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .

  • Our Excellence Spotlight series celebrates and showcases the remarkable journeys and achievements of RQM+ employees; the same employees who are committed to technical excellence and make a significant impact on our clients.

    Our ๐—˜๐˜…๐—ฐ๐—ฒ๐—น๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฆ๐—ฝ๐—ผ๐˜๐—น๐—ถ๐—ด๐—ต๐˜ series of interviews with RQM+ employees returns today as Christine Santagate, RAC is joined by enthusiastic Jordi Labs Technical Program Lead Joshua Nott. ๐Ÿ‘‹

    ๐ŸŽฅ Hear how Josh's journey from biochemistry to analytical chemistry led him to excel in customer service and technical problem solving. Josh also shares:

    โœ”๏ธ His transition into project management

    โœ”๏ธ How he builds rapport with clients

    โœ”๏ธ His experience teaching and mentoring students

    โœ”๏ธ Valuable advice for those starting their careers

    We think you can learn from Josh's expertise and passion for analytical chemistry and hope you enjoy!

    ๐Ÿ”ฌ We'll be highlighting more Jordi Labs staff in the coming weeks.

    --

    ๐Ÿ“น โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ View and share this clip on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ฒ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Follow RQM+ on LinkedIn.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ’ผ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ Check out our open positions.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“š โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ See on-demand content in our Knowledge Center.โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ 

    ๐Ÿ“ If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ our contact formโ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ โ .